title: Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol.
authors.affiliation: Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.
authors.forename: E M C
authors.initials: EM
authors.lastname: Driessen
authors.affiliation: Interfant-99 Trial Data Center, Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Monza, Italy.
authors.forename: P
authors.initials: P
authors.lastname: de Lorenzo
authors.affiliation: Chilean National Pediatric Oncology Group, PINDA, Roberto del Rio Hospital, Universidad de Chile, Santiago, Chile.
authors.forename: M
authors.initials: M
authors.lastname: Campbell
authors.affiliation: Department of Pediatric Hematology/Oncology, Hospital de Pediatría Prof. Dr. Juan P. Garrahan, Buenos Aires, Argentina.
authors.forename: M
authors.initials: M
authors.lastname: Felice
authors.affiliation: Department of Hemato-Oncology, Hôpital Unviversitaire des Enfants Reine Fabiola (ULB), Brussels, Belgium.
authors.forename: A
authors.initials: A
authors.lastname: Ferster
authors.affiliation: UK Children's Cancer Study Group, Great Ormond Street Hospital for Children, London, UK.
authors.forename: I
authors.initials: I
authors.lastname: Hann
authors.affiliation: Department of Paediatric Haematology, Sheffield Children's Hospital, Sheffield, UK.
authors.forename: A
authors.initials: A
authors.lastname: Vora
authors.affiliation: Nordic Society of Paediatric Haematology and Oncology, University of Helsinki, Helsinki, Finland.
authors.forename: L
authors.initials: L
authors.lastname: Hovi
authors.affiliation: University Medical Center Hamburg-Eppendorf, Clinic of Pediatric Hematology and Oncology, Hamburg, Germany.
authors.forename: G
authors.initials: G
authors.lastname: Escherich
authors.affiliation: Hong Kong Paediatric Haematology and Oncology Study Group, Prince of Wales Hospital, Hong Kong, China.
authors.forename: C K
authors.initials: CK
authors.lastname: Li
authors.affiliation: St. Anna Children's Cancer Research Institute and St. Anna Children's Hospital, Department of Pediatrics, Medical University School, Vienna, Austria.
authors.forename: G
authors.initials: G
authors.lastname: Mann
authors.affiliation: Departement of Pediatric Hematology, Hôpital Robert-Debré, Paris, fort he FRALLE group, Paris, France.
authors.forename: T
authors.initials: T
authors.lastname: Leblanc
authors.affiliation: Associazione Italiana Ematologia Oncologia Pediatrica, Italy Bambino Gesù Children's Hospital, Rome, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Locatelli
authors.affiliation: Associazione Italiana Ematologia Oncologia Pediatrica, Italy Bambino Gesù Children's Hospital, Rome, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Biondi
authors.affiliation: St Jude Children's Research Hospital, Memphis, TN, USA.
authors.forename: J
authors.initials: J
authors.lastname: Rubnitz
authors.affiliation: Berlin-Frankfurt-Münster Study Group, Hannover, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Schrappe
authors.affiliation: Dana-Farber Cancer Institute ALL Consortium, Boston, MA, USA.
authors.forename: L
authors.initials: L
authors.lastname: Silverman
authors.affiliation: Czech Pediatric Haematology, Prague, Czech Republic.
authors.forename: J
authors.initials: J
authors.lastname: Stary
authors.affiliation: Australian and New Zealand Children's Haematology and Oncology Study Group, North Adelaide, Australia.
authors.forename: R
authors.initials: R
authors.lastname: Suppiah
authors.affiliation: Polish Pediatric Leukemia and Lymphoma Study Group, and Department of Pediatric Hematology and Oncology, Zabrze, Medical University of Silesia, Katowice, Poland.
authors.forename: T
authors.initials: T
authors.lastname: Szczepanski
authors.affiliation: Interfant-99 Trial Data Center, Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Monza, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Valsecchi
authors.affiliation: Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.|Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.|Dutch Childhood Oncology Group, The Hague, the Netherlands.
authors.forename: R
authors.initials: R
authors.lastname: Pieters
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000401:mortality; D012008:Recurrence; D016896:Treatment Outcome